Akagi S,Fujiwara T,Nishida M,Okuda A,Nagao Y,Okuda T,Tokuda H,Takayanagi T H .2019 .The effectiveness of rebamipide mouthwash therapy for radiotherapy and chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: A systematic review and meta-analysis. Jpn. J. Pharm. Health Care Sci., 5(1) : 1-7.
Andreev DN,Maev IV .2020 .Rebamipide: Evidence base for use in gastroenterology. , 92(12) : 97-104.
Andreev DN,Maev IV,Dicheva DT .2019 .Efficiency of the inclusion of rebamipide in the eradication therapy for Helicobacter pylori Infection: Meta-analysis of randomized controlled studies. J. Clin. Med, 8(9) : 1498.
Castaman G,Borchiellini A,Santagostino E,Radossi P,Aksu S,Yilmaz M,Serban M,Uscatescu V,Truica C,Fasulo MR,Mancuso ME,Paladino E,Valpreda A,Guarnieri C,Macchia R,Scarpellini M,Mathew P and M Morfini M .2020 .Non-Compartment and compartmental pharmacokinetics, efficacy and safety of Kedrion FIX concentrate. Eur.J.Pharm.Sci., 153 : 105485.
Chen C,Zheng QS,Li LJ,LI X,Xu L X .2020 .Comparison of the calculation approaches of AUC in non-compartment model pharmacokinetics. Chin. J. Clin. Pharmacol, 25(12) : 1381.
Chen W,Ming Yeo SC,Chuang XF,Lin HS .2016 .Determination of pinostilbene in rat plasma by LCMS/MS: Application to a pharmacokinetic study. J. Pharm. Biomed. Anal., 120 : 316-321.
Cho HY,Yoon H,Park GK,Lee LB .2009 .Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: A randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers. Clin. Ther, 31(11) : 2712-2721.
Cho HY,Yoon H,Park GK,Lee YB .2009 .Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: A randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers. Clin. Ther, 31(11) : 2712-2721.
Decosterd LA,Mercier T,Ternon B,Cruchon S,Guignard N,Lahrichi S,Pesse B,Rochat B,Burger R,Lamoth F,Pagani JL,Eggimann P,Csajka C,Choong E,Buclin T,Widmer N,André P,Marchetti O .2020 .Validation and clinical application of a multiplex high performance liquid chromatography-tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections. J. Chromatogr. B., 1157 : 122160.
Elkady EF,Fouad MA,Alshoba N,Mahmoud ST .2020 .Validated LC-MS/MS method for the determination of some prescribed CNS drugs: Application to an in vivo pharmacokinetic study of drug-herb metabolic interaction potential of khat. , 158 : 105261.
He QJ,Liu MJ,Rong Z,Liang HX,Xu XX,Sun SS,Lei Y,Li P,Meng H,Zheng Ri,Bi YL,Chen X,Wang BM,Zhao JW,Jiang K JW .2022 .Rebamipide attenuates alcohol-induced gastric epithelial cell injury by inhibiting endoplasmic reticulum stress and activating autophagy-related proteins. Eur. J. Pharmacol., 922 : 174891.
Hou D,Yang MY,Hu ZP,Yang LJ .2020 .Effects of rebamipide for chronic atrophic gastritis: A protocol for systematic review and meta-analysis. Medicine, 99(25) : e20620.
Jeoung MK,Kim CS,Kim NH,Hong JT,Chung YB,Park Y,Kim KS,Moon DC .2004 .Determination of rebamipide in human plasma by HPLC. J. Liq. Chromatogr. Relat. Technol., 27(12) : 1925-1935.
Ma O,Orfanidis A,Brousa E,Kevrekidis DP,Zagelidou H,Raikos N H .2023 .Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometric method for the determination of 25 psychoactive drugs in cerumen and its application to real postmortem samples. Forensic Toxicol, 41(1) : 94-104.
Malhotra C,Singh H,Jain AK,Gupta A,Ram J .2020 .Efficacy of 2% rebamipide suspension for vernal keratoconjunctivitis: a clinical comparison with topical immune modulators cyclosporine and tacrolimus. Ocul. Immunol. Inflammation, 30(5) : 1083-1091.
Manglani UR,Khan IJ,Soni K,Loya P,Saraf MN .2006 .Development and validation of HPLC-UV method for the estimation of rebamipide in human plasma. Indian J. Pharm. Sci., 68(4) : 475-478.
Narala A,Guda S,Veerabrahma K S .2019 .Lipid nanoemulsions of rebamipide: Formulation, characterization, and in vivo evaluation of pharmacokinetic and pharmacodynamic effects. AAPS Pharm. Sci. Tech, 20(26) : 1-9.
Nasiri A,Jahani R,Mokhtari S,Yazdanpanah H,Daraei B,Faizia M,Kobarfard F M .2021 .Overview, consequences, and strategies for overcoming matrix effects in LC-MS analysis: A critical review. Analyst., 146(20) : 6049-6063.
Ngo L,Yoo HD,Tran P,Cho HY,Lee YB .2017 .Population pharmacokinetic analysis of rebamipide in healthy Korean subjects with the characterization of atypical complex absorption kinetics. J. Pharmacokinet. Pharmacodyn., 44 : 291-303.
Nicolò AD,Cantù M,D'Avolio A .2017 .Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect. Bioanalysis, 9(14) : 1093-1105.
Otsubo K,Morita S,Uchida M,Yamazaki K,Kanbe T,Shimizu TF .1991 .Synthesis and antiulcer activity of optical isomers of 2-(4- chlorobenzoylamino)-3-[2 (1H)-quinolinon-4-yl] propionic acid (rebamipide). Chem. Pharm. Bull., 39(11) : 2906-2909.
Raposo F and Barceló D .2021 .Challenges and strategies of matrix effects using chromatography-mass spectrometry: An overview from research versus regulatory viewpoints. Trends Anal. Chem, 134 : 116068.
Rudzki PJ,Gniazdowska E,Buś-Kwaśnik K .2018 .Quantitative evaluation of the matrix effect in bioanalytical methods based on LC-MS: A comparison of two approaches. J. Pharm. Biomed. Anal., 155 : 314-319.
Sakane Y,Yamaguchi M,Shiraishi A .2019 .Retrospective observational study on rebamipide ophthalmic suspension on quality of life of dry eye disease patients. J. Ophthalmol, 8145731 : .
Sonawane S and Paraag G .2011 .Optimization of forced degradation using experimental design and development of a stability-indicating liquid chromatographic assay method for rebamipide in bulk and tablet dosage form. Sci. Pharm, 79(1) : 85-96.
Uchida M,Tabo F,Morita S,Kanbe T,Nakagawa K .1986 .-quinolinone derivatives as gastric antiulcer active agents. synthesis and antiulcer activity of the metabolites of 2-(4- chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl] propionic acid. Chem. Pharm. Bull., 34(11) : 4821-4824.
Xu N,Zhang C,Jing LL,Mou SJ,Cao XL,Yu ZH .2021 .Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury. Int. Immunopharmacol., 90 : 107136.
Zhao Y,Liu GW,Shen JX,Aubry AF .2014 .Reasons for calibration standard curve slope variation in LC-MS assays and how to address it. Bioanalysis, 6(11) : 1439-1443.
Zhu SY,Zheng ZJ,Peng HW,Sun JB,Zhao XE,Liu HW .2020 .Quadruplex stable isotope derivatization strategy for the determination of panaxadiol and panaxatriol in foodstuffs and medicinal materials using ultra high performance liquid chromatography tandem mass spectrometry. J. Chromatogr. A., 1616 : 460794.
Zvyaglova MY,Knyazev OV,Parfenov AI .2020 .Pharmacological and clinical feature of rebamipide: New therapeutic targets. Ter, 92(2) : 104-111.